General Information
Revision date
2022-01-18
Product name
Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
Manufacturer Name
Hetero Labs Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
GHS Information
Signal word
US Hazard overview
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage.
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Drugs in the finished state and intended for the final user are not subject to labeling in the US, EU or Canada. Please consult the prescribing/packaging information. The classification and labelling listed below is for bulk Emtricitabine/Tenofovir Disoproxil Fumarate Tablets Regulation (EC)
CLP CLASSIFICATION
H318 - Causes serious eye damage.
Hazard statements
CLP/GHS precautionary P280 - Wear eye/face protection. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a Poison Center or doctor/ Physician Risk (R) Phrase(s) R41 - Risk of serious damage to eyes.
Precautionary statements
S2 - Keep out of reach of children. S25 - Avoid contact with eyes. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S39 - Wear eye/face protection.
2.3 Other hazards
Adverse effects seen with therapeutic use of Emtricitabine/Tenofovir Disoproxil Fumarate include diarrhea, nausea, abdominal pain, flatulence, pancreatitis, weakness, headache, dizziness, insomnia, abnormal dreams, allergic reactions, skin discoloration, rash, muscular weakness, bone problems, including bone pain, softening or thinning (which may lead to fractures), changes in immune system (Immune Reconstitution Syndrome). Serious effects including lactic acidosis, renal impairment, including cases of acute renal failure, and effects on the liver, including hepatomegaly and developing fat in liver. The recommended dose of Emtricitabine/Tenofovir Disoproxil Fumarate Tablets is one tablet per day (containing 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate)
Signal word
US Hazard overview Warning Causes eye irritation. Used as an antiretroviral agent for the treatment of HIV-1 infection.